Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.52 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.49 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974165 | 0.89 | NPC1 (0.53) | MAPTADRA2AADRA2BADRA2CSLC2A1 | |
| SCHEMBL27617094 | 0.87 | RAB9A (0.56) | MAPTADRA2AADRA2BADRA2CSLC2A1 | |
| SCHEMBL7039450 | 0.87 | KDM4E (0.59) | MAPTLMNAKMT2AALDH1A1MEN1 | |
| SCHEMBL17675603 | 0.85 | MAPT (0.49) | MAPTADRA2AADRA2BADRA2CSLC2A1 | |
| SCHEMBL71038 | 0.84 | LMNA (0.54) | MAPTLMNAKMT2AALDH1A1MEN1 | |
| SCHEMBL10912996 | 0.84 | HSPB1 (0.41) | MAPTADRA2AADRA2BADRA2CSLC2A1 | |
| SCHEMBL5142118 | 0.82 | SMN1; SMN2 (0.50) | MAPTADRA2AADRA2BADRA2CSLC2A1 | |
| Hydrochloric Acid SCHEMBL27598115 | 0.82 | LMNA (0.53) | MAPTADRA2AADRA2BADRA2CLMNA | |
| SCHEMBL695031 | 0.81 | RAB9A (0.43) | MAPTADRA2AADRA2BADRA2CSLC2A1 | |
| SCHEMBL4667403 | 0.81 | MAPT (0.51) | MAPTADRA2AADRA2BADRA2CSLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455690-B2 | Method for producing arylhydroxylamine | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-04 | — | — | US | disclosed |
| US-20100113830-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2154125-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | Wako Pure Chemical Industries, Ltd. (JP) | 2010-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113830-A1 | METHOD FOR PRODUCING ARYLHYDROXYLAMINE | PAH, APEH, HPD | MAPT 4363/4885ADRA2A 924/4885ADRA2B 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.